DK1233784T3 - Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering - Google Patents

Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering

Info

Publication number
DK1233784T3
DK1233784T3 DK00992589T DK00992589T DK1233784T3 DK 1233784 T3 DK1233784 T3 DK 1233784T3 DK 00992589 T DK00992589 T DK 00992589T DK 00992589 T DK00992589 T DK 00992589T DK 1233784 T3 DK1233784 T3 DK 1233784T3
Authority
DK
Denmark
Prior art keywords
biological molecules
methods
lyophilization
preparations
stabilizing biological
Prior art date
Application number
DK00992589T
Other languages
English (en)
Inventor
Irina Esikova
Sidney Wolfe
James Thomson
Hora Maninder
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22611688&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1233784(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of DK1233784T3 publication Critical patent/DK1233784T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK00992589T 1999-12-02 2000-12-01 Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering DK1233784T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16848699P 1999-12-02 1999-12-02
PCT/US2000/042484 WO2001041800A2 (en) 1999-12-02 2000-12-01 Compositions and methods for stabilizing biological molecules upon lyophilization

Publications (1)

Publication Number Publication Date
DK1233784T3 true DK1233784T3 (da) 2008-09-01

Family

ID=22611688

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00992589T DK1233784T3 (da) 1999-12-02 2000-12-01 Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering

Country Status (10)

Country Link
EP (2) EP2292263A3 (da)
JP (2) JP4948731B2 (da)
AT (1) ATE400296T1 (da)
CA (1) CA2393298C (da)
CY (1) CY1108382T1 (da)
DE (1) DE60039450D1 (da)
DK (1) DK1233784T3 (da)
ES (1) ES2307553T3 (da)
PT (1) PT1233784E (da)
WO (1) WO2001041800A2 (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1233784T3 (da) 1999-12-02 2008-09-01 Novartis Vaccines & Diagnostic Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering
PT2332581E (pt) 2001-01-23 2015-10-16 Sanofi Pasteur Inc Vacina meningocócica tri- ou tetravalente de conjugados de polissacárido e crm-197
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
EP1409013B1 (en) * 2001-07-26 2009-11-18 Novartis Vaccines and Diagnostics S.r.l. Vaccines comprising aluminium adjuvants and histidine
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
MXPA05004528A (es) 2002-11-01 2005-07-26 Glaxosmithkline Biolog Sa Composicion inmunogenica.
ES2461350T3 (es) 2003-01-30 2014-05-19 Novartis Ag Vacunas inyectables contra múltiples serogrupos de meningococos
WO2005011740A1 (en) * 2003-08-05 2005-02-10 Fuji Photo Film B.V. Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions
CA2542777C (en) 2003-10-23 2016-02-02 Chiron Corporation Stabilised compositions
GB0404586D0 (en) * 2004-03-01 2004-04-07 Britannia Pharmaceuticals Ltd Improvements in or relating to organic materials
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
LT2351578T (lt) 2005-06-27 2017-04-10 Glaxosmithkline Biologicals S.A. Vakcinų gavimo būdas
US10828361B2 (en) 2006-03-22 2020-11-10 Glaxosmithkline Biologicals Sa Regimens for immunisation with meningococcal conjugates
ES2383209T3 (es) 2006-03-22 2012-06-19 Novartis Ag Regímenes para la inmunización con conjugados meningococicos
TW200806315A (en) * 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
TW201009337A (en) * 2008-05-30 2010-03-01 Intervet Int Bv Analytical method to monitor vaccine potency and stability
KR101593285B1 (ko) * 2008-10-29 2016-02-11 아블린쓰 엔.브이. 단일 도메인 항원 결합 분자의 제형
CA2739352C (en) 2008-10-29 2021-07-13 Wyeth Llc Methods for purification of single domain antigen binding molecules
PT3170508T (pt) 2010-06-04 2020-01-16 Wyeth Llc Formulações de vacinas
RU2580620C2 (ru) 2010-08-23 2016-04-10 ВАЙЕТ ЭлЭлСи СТАБИЛЬНЫЕ КОМПОЗИЦИИ АНТИГЕНОВ Neisseria meningitidis rLP2086
WO2012032489A1 (en) 2010-09-10 2012-03-15 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
US20140112950A1 (en) 2011-03-02 2014-04-24 Manmohan Singh Combination vaccines with lower doses of antigen and/or adjuvant
MX346245B (es) 2011-06-01 2017-03-13 Univ Xiamen Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria.
JP2015500864A (ja) * 2011-12-23 2015-01-08 ノバルティス アーゲー 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）に対して免疫するための安定な組成物
IN2012MU00206A (da) 2012-01-20 2013-08-09
JP2015509963A (ja) 2012-03-08 2015-04-02 ノバルティス アーゲー Ｔｌｒ４アゴニストを含む混合ワクチン
CA2865745C (en) 2012-03-09 2018-01-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
RU2019101166A (ru) * 2012-05-30 2020-03-02 Дзе Брихэм Энд Уимен`З Хоспитал, Инк. Композиции полисахаридов и способы применения
JP2015527310A (ja) * 2012-06-28 2015-09-17 アンサン バイオファーマ, インコーポレイテッドAnsun Biopharma, Inc. 下気道および中枢気道への送達用微粒子製剤ならびに製造方法
WO2014009971A2 (en) * 2012-07-07 2014-01-16 Bharat Biotech International Limited Non-alcoholic vaccine compositions free from animal- origin and process for preparation thereof
EP2892553A1 (en) 2012-09-06 2015-07-15 Novartis AG Combination vaccines with serogroup b meningococcus and d/t/p
AR092896A1 (es) 2012-10-03 2015-05-06 Novartis Ag Composiciones inmunogenicas
US20150320852A1 (en) 2012-12-18 2015-11-12 Glaxosmithkline Biologicals Sa Conjugates for protecting against diphtheria and/or tetanus
US9802987B2 (en) 2013-03-08 2017-10-31 Pfizer Inc. Immunogenic fusion polypeptides
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
AU2016221318B2 (en) 2015-02-19 2020-06-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
US10183070B2 (en) 2017-01-31 2019-01-22 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
US12128094B2 (en) 2018-11-06 2024-10-29 Glaxosmithkline Biologicals Sa Immunogenic compositions comprising OMVs, an acellular pertussis antigen, a tetanus toxoid and a diphtheria toxoid
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis
EP4034157A1 (en) 2019-09-27 2022-08-03 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
GB202208089D0 (en) * 2022-06-01 2022-07-13 Glaxosmithkline Biologicals Sa Immunogenic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
CA2226575C (en) * 1995-07-27 2011-10-18 Genentech, Inc. Stabile isotonic lyophilized protein formulation
DK1233784T3 (da) 1999-12-02 2008-09-01 Novartis Vaccines & Diagnostic Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering

Also Published As

Publication number Publication date
CA2393298A1 (en) 2001-06-14
CY1108382T1 (el) 2014-02-12
ATE400296T1 (de) 2008-07-15
CA2393298C (en) 2011-02-01
JP2003516361A (ja) 2003-05-13
JP2011137047A (ja) 2011-07-14
WO2001041800A3 (en) 2002-01-03
WO2001041800A2 (en) 2001-06-14
EP1233784A2 (en) 2002-08-28
EP2292263A3 (en) 2011-07-27
ES2307553T3 (es) 2008-12-01
EP2292263A2 (en) 2011-03-09
DE60039450D1 (de) 2008-08-21
PT1233784E (pt) 2008-11-03
EP1233784B1 (en) 2008-07-09
JP4948731B2 (ja) 2012-06-06
WO2001041800A9 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
CY1108382T1 (el) Συνθεσεις και μεθοδοι για σταθεροποιηση βιολογικων μοριων κατα την λυοφιληση
DK1041072T3 (da) Dioxocyclopentylhydroxamsyrer
ATE405647T1 (de) Rekombinantes gelatin in impstoffen
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
PL361341A1 (pl) Nowa kompozycja farmaceutyczna
DK0535091T3 (da) Knogleinducerende farmaceutiske formuleringer
EA200100337A1 (ru) Стабильные жидкие составы ботулинического токсина
CY1108706T1 (el) Ανοσορυθμιστης
EA200401579A1 (ru) Замещенные соединения метациклина (варианты), фармацевтическая композиция (варианты) и способ лечения чувствительного к тетрациклину состояния млекопитающего (варианты)
PT1347971E (pt) Inibidores tiazolilicos de tirosina-cinases da familia tec
ATE246514T1 (de) Paclitaxel enthaltende arzneimittel
BR9201015A (pt) Conjugado de proteina,composto,processo para preparar o conjugado,composicoes farmaceuticas e uso
EA200000840A1 (ru) Антивирусные производные пиримидина
BR9908015A (pt) Composições que compreendem vìrus e métodos para concentração de preparações de vìrus
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
FI942186A0 (fi) Sytokiinituotantoa indusoivat uretaanit ja ureat
ATE253063T1 (de) 5-ht1f-agonisten
ATE293159T1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
DK1261606T3 (da) Substituerede oxazolidinoner og deres anvendelse inden for blodkoagulationsområdet
EP1185545A4 (en) CD4-INDEPENDENT HIV ENVELOPE PROTEINS FOR USE AS VACCINES AND THERAPEUTIC AGENTS
EA200400530A1 (ru) Перекрестно-сшитые антибиотики "гликопептид-цефалоспорин"
DK1219301T3 (da) Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner
SE0001916D0 (sv) Novel formulation